AlphaMadera's AlphaVal page computes Mettler-Toledo International Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag MTD as undervalued, fairly valued, or overvalued.

What is Mettler-Toledo International Inc.'s fair value?

Fair value for MTD is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value MTD?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from MTD's most recent reported fundamentals.

MTD - Mettler-Toledo International Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $1,383.80 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Strong

Trading 55.8% above fair value

Current Price $1298.17

Bear Case $666.58 48.7% downside ($666.58 - $1,298.17) / $1,298.17 = -48.7% $43.31 × 12x P/E

Fair Value $833.23 35.8% downside ($833.23 - $1,298.17) / $1,298.17 = -35.8% $43.31 × 15x P/E

Bull Case $999.88 23.0% downside ($999.88 - $1,298.17) / $1,298.17 = -23.0% $43.31 × 18x P/E

Adjust Assumptions

P/E Multiple

15.0x

Adjusted EPS

43.31$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 30.0x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $1383.80 from 19 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $833.23 per share.

Warnings

ℹ Wall Street's average price target is $1383.80 (from 19 analysts). Our estimate is 53% below the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples